IHS Chemical Week

Regions :: North America :: U.S.

India's foreign investment board clears Mylan's $1.6-billion acquisition of Agila

2:45 AM MDT | August 28, 2013 | Natasha Alperowicz

India’s Foreign Investment Promotion Board (New Delhi) has cleared Mylan's (Canonsburg, PA) proposal to acquire Agila Specialties (Bangalore, India), a subsidiary of pharma firm Strides Arcolab.   Mylan on 27 February announced that it had signed a definitive agreement to acquire Agila, a developer, manufacturer, and marketer of generic injectable products, from Strides for approximately $1.6 billion in cash plus contingent payments of up to $250 million subject to conditions. Mylan says it has obtained $1 billion in committed financing, which...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa